Safety Study of CC312 in Autoimmune Disease Patients

NCT06888960 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus (SLE)
Idiopathic Inflammatory Myopathy (IIM)
Systemic Sclerosis (SSc)
Rheumatoid Arthritis (RA)
Primary Immune Thrombocytopenia (ITP)
Autoimmune Hemolytic Anemia

Interventions

BIOLOGICAL: CC312

Sponsor

CytoCares Inc